| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.059 | 0.2 |